Aradigm Doses First Patient In Long-Term Phase 2 Study Of A Novel Inhaled Ciprofloxacin Formulation For The Management Of Respiratory Infections

Aradigm Corporation (OTCBB:ARDM) (the “Company”) announced that the first patient was dosed in a 6-month, multicenter, international Phase 2 clinical trial of a novel version of inhaled ciprofloxacin (ARD-3150) in 40 adult patients with non-cystic fibrosis bronchiectasis. The randomized, double-blind, placebo-controlled trial will be conducted in Australia and New Zealand.

Go to Source

People who read this also read

• Aradigm Doses First Patient In Its Second Phase 2b Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Bronchiectasis Patients
  Aradigm Corporation (OTCBB:ARDM) (the "Company") announced that it dosed the first patient in the U.S. as part of its ORBIT-1 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) trial, an international, randomized, double-blind, placebo-controlled Phase 2b study designed to evaluate the Com...
• Radiofrequency surgery for the treatment of obstructive sleep apnea: Short-term and long-term results
  Conclusion: RF is a minimally invasive and effective procedure that results in long-term success for patients with a relatively low BMI and mild to moderate OSA without nasal obstruction. However, a recommendation concerning weight control and a regular follow-up are important because some patients ...
• Pathogenesis of Riemerella anatipestifer in turkeys after experimental mono-infection via respiratory routes or dual infection together with the avian metapneumovirus.
  Riemerella anatipestifer (RA) is the causative agent of septicaemic and exudative diseases in a variety of bird species. Despite numerous outbreaks, little is known about the pathogenicity of RA for turkeys. We investigated the development of RA-induced disease in commercial turkey poults following ...
• Costs For Long-Term Care Rise, Home Health Care Costs Fairly Stable
  U.S. News & World Report Blog: "Institutional costs for long term care continued to post big increases last year even as the economy sputtered along, according to the seventh annual Cost of Care survey from Genworth Financial, a major seller of long term care insurance. The good news in the surv...
• The Heart May Be Weakened More Than Previously Thought By Long-Term Anabolic Steroid Use
  Long-term anabolic steroid use may weaken the heart more than previously thought and may increase the risk of heart failure, according to research reported in Circulation: Heart Failure, an American Heart Association journal. Anabolic-androgenic steroids mimic the naturally occurring testosterone, a...